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Humans encountered physiological
challenges as soon we began to leave the
ground, ﬁrst with balloons, then with
planes, and more recently via rockets. Early
high-altitude balloon ﬂight exposed the
sojourners to extreme cold and potentially
lethal hypoxia (West, 1982). As planes
became more powerful and manoeuvrable,
pilots experienced severe G-forces that
could limit brain perfusion and cause
loss of consciousness. The problems of
temperature, hypoxia and G-forces have all
been solved with relatively straightforward
countermeasures including supplemental
oxygen, pressurized environments,
improved clothing, and G-suits along with
straining manoeuvres.
The solutions to these problems have
all also had signiﬁcant translational
implications with many ﬁnding a second
homeinclinical medicine.Forexample, the
fundamental discoveries and engineering
breakthroughs required to understand
how humans respond to high G-forces,
found second homes after the Second
World War in the emerging ﬁelds of
cardiac catheterization, cardiac surgery and
critical care medicine. Many of the key
advances were made by the legendary
physician–scientist Earl Wood, who worked
at my institution, the Mayo Clinic, during
and after the Second World War (see
the obituary of Earl Wood in the New
York Times, 26 March 2009). Additionally,
numerous advances in respiratory physio-
logy with subsequent clinical applications
owe their genesis to observations made at
high altitude including those made during
aviation.
In contrast to the high G-forces
experienced by the pilots of high-
performance planes, weightlessness during
space ﬂight creates major problems for
astronauts. The adaptations (or perhaps
maladaptations) to space ﬂight include
rapid cardiovascular deconditioning and
loss of blood volume, skeletal muscle
wasting, and reductions in bone density.
Endurance exercise training and acute
bouts of high-intensity exercise can
ameliorate much of the cardiovascular
deconditioning and changes in blood
volume associated with both medium-term
(weeks) and long-term weightlessness
(months). Additionally, head-down tilt
bedrest appears to be a useful analogue
for the cardiovascular deconditioning that
occurs with prolonged space ﬂight, making
ground based studies highly informative
(Engelke et al. 1996; Guinet et al. 2009).
Along with cardiovascular deconditioning
there are also losses of both skeletal muscle
mass and bone density with space ﬂight.
In a recent issue of The Journal of Physio-
logy, Fitts et al. (2010) reported that
180 days of space ﬂight causes marked
atrophy and force loss of skeletal muscle
biopsy-derived ﬁbres from space station
crew members. In this context, the effects
of space ﬂight were especially evident in
type 1 ﬁbres of ‘anti-gravity’ muscles, like
the soleus. Importantly, and in contrast to
cardiovascular deconditioning, these effects
were largely resistant to amelioration by
concurrentexercisetraininginspace.Along
these lines there are a number of caveats
and clinical observations that either inform
or are informed by these ﬁndings.
First, modern orthopaedic surgery
has abandoned, when possible, extreme
immobilization and this practice appears
to have improved both the speed and
efﬁcacy of reconstructive surgery in a
variety of settings. This trend includes
rehabilitation from conditions like total
joint replacement in older patients, and
also knee reconstruction in elite athletes.
Orthopaedic surgeons and physical
therapists have learned the hard way
that extreme skeletal muscle inactivity is
devastating, slows recovery, and can lead
even young healthy patients to a state where
full recovery is limited.
Second, crew members on the inter-
national space station could be generically
described as middle-aged. If 6 months of
minimal gravitational stress and physical
activity can be associated with severe loss
of muscle function, what does 20 or
30 years of physical inactivity do? There
is already evidence that extreme physical
inactivity for only 10 days can evoke a
varietyofmetabolicchangesthatpredispose
the physically inactive to conditions like
diabetes and obesity (Olsen et al. 2008).
Third, frailty independent of other risk
factors is a major contributor to premature
death and disability in older humans
(Schatz, 2002). This becomes even more
apparent in individuals in their 70sand 80s.
If effective countermeasures are developed
for prolonged space ﬂight, will they have
implications for preventing, reducing, or
reversing frailty in the elderly?
Fourth,whataboutprolongedspaceﬂight?
Exploration of Mars will require a mission
of 3–4 years. Will muscle (and bone) loss
be the scurvy of modern-day exploration,
or will space ﬂight make new contributions
to medicine similar to those made by pre-
vious explorers in the areas of nutritionand
hygiene? Along these lines, the discovery
by Lind in the 1700s that citrus fruit
(vitamin C) could treat scurvy is generally
considered the ﬁrst clinical trial. It is also
an excellent example of how exploration,
pathophysiology and medicine sometimes
intersect for extremely applied reasons
(Thomas, 1997).
In summary, the paper by Fitts and
colleagues shows that new and innovative
countermeasures will be required as human
exploration of space continues. If the
history of these countermeasures from
earlier aviation- and exploration-based
experiences is any guide, the spinoffs for
clinical medicine are likely to be large.
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